Cardioprotection mediated by rosiglitazone, a peroxisome proliferator-activated receptor gamma ligand, in relation to nitric oxide. [electronic resource]
- Basic research in cardiology Jan 2007
- 80-9 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
0300-8428
10.1007/s00395-006-0613-4 doi
Animals Blotting, Western Hypoglycemic Agents--pharmacology In Vitro Techniques Mice Mice, Inbred C57BL Mice, Knockout Nitric Oxide--pharmacology Nitric Oxide Synthase Type III--metabolism PPAR gamma--agonists Rosiglitazone Thiazolidinediones--pharmacology